GlassScriptPhysician profile
Michael Brooks Staff
NPI 1326104290
$816.65
in general payments reported to CMS, 2019-2025
11 companies · $50.30 in 2025
The $50.30 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $230 · 2022: $204 · 2023: $223 · 2024: $109 · 2025: $50.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $188.31 | 2021-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $170.39 | 2021-2025 | Breztri, Farxiga |
| Lilly USA, LLC | $125.50 | 2021-2023 | Jardiance, Mounjaro |
| Dexcom, INC. | $95.82 | 2021-2023 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.26 | 2021-2023 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.56 | 2021-2023 | Tradjenta, Jardiance, Synjardy |
| Grifols USA, LLC | $38.67 | 2021-2024 | Prolastin-C Liquid |
| Abbvie INC. | $19.00 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.34 | 2022 | |
| Genentech USA, INC. | $15.99 | 2021 | |
| Mylan Specialty L.P. | $12.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Staff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.